Latest Capital Raise News

ReNu Energy Limited has received conditional approval from the ASX to reinstate its listing, contingent on completing a significant capital raise and meeting key regulatory requirements. The company will also rebrand as Janus Electric Holdings as part of its refreshed market strategy.

Zimi Limited has paused its planned capital raising amid ongoing talks, while revealing strong operational momentum including $1.42 million in open orders and expanded market partnerships.

FOS Capital has acquired Melbourne-based lighting design consultancy Glowing Structures for $700,000, aiming to deepen its footprint in the lighting services sector. The deal includes cash and shares, with Glowing Structures’ founder staying on as Managing Director.

Mighty Kingdom Limited has completed its entitlement offer, raising approximately A$475,000 through the issuance of 95 million new shares, yet a significant shortfall remains to be placed with investors.

Mirrabooka Investments Limited has launched a $85 million non-renounceable entitlement offer at $3.06 per share, inviting eligible shareholders to increase their holdings with a top-up facility. The offer aims to bolster the company’s investment capacity amid evolving market conditions.

Mirrabooka Investments Limited has announced a 1-for-7 entitlement offer priced at $3.06 per share, aiming to raise approximately $85 million to capitalize on emerging investment opportunities.

Imdex Limited reported a stabilisation in global exploration activity after a prolonged downturn, highlighting resilience despite a 19% revenue dip in 3Q25 and outlining a growth strategy focused on technology and integrated solutions.

Epsilon Healthcare reports ongoing operational challenges post-voluntary administration while unveiling a new pharmacy subsidiary aimed at diversifying revenue streams and rebuilding market confidence.

A shareholder has lodged an application with the Takeovers Panel challenging FBR Limited’s upcoming extraordinary general meeting resolutions related to significant share placements and funding arrangements with Fidelity International.

Enlitic Inc. has been reinstated to trading on the ASX following its announcement of a new equity raise, signaling renewed investor interest in the health technology firm.

Enlitic has signed a binding MoU with GE HealthCare to deliver up to A$50 million in migration services over five years, contingent on a A$10 million equity raise that the company has now initiated.

Proteomics International Laboratories Ltd is raising up to $5.5 million through a $4 million placement and a $1 million Share Purchase Plan at $0.37 per share, offering shareholders a discounted entry and free attaching options.